On-Demand Webinar

Evolution of a Fully Automated Acoustic Ejection Mass Spectrometry (AEMS) Platform for Lead Discovery and Optimization

Download the On-Demand Webinar Now!

HighRes Biosolutions is excited to present an on-demand webinar, co-sponsored by Cambridge Innovation Institute. In this webinar, we discuss how important it is to design automation that not only meets current needs but is also future-flexible.

In this on-demand webinar, you will hear from Peter Chase and Wilson Shou from Bristol Myers Squibb (BMS), who will explain how BMS successfully deployed acoustic ejection mass spectrometry (AEMS, or Echo® MS) technology to meet their current needs while setting them up for future flexibility.
Key takeaways from the webinar:
  • Designing automation that is future-flexible
  • Integrating novel instrumentation onto automation
  • Managing instrument integration lifecycle (driver development, error capture, data movement)
  • Leveraging high-throughput mass spectrometry (HTMS) for label-free screening
  • Research collaboration on novel technologies

To gain access, register now by simply filling out the form.

Speaker Information

Peter Chase Portrait
Peter Chase, Scientific Director, Bristol Myers Squibb

Peter has 20+ years an an automation engineer/scientist in the field of early drug discovery executing lead discovery (uHTS), lead evaluation (SAR/SLR), lead profiling (ADME-TOX) and compound management operations.

Wilson Shou Portrait
Wilson Shou, Director, Bristol Myers Squibb

Wilson has 20+ years of experience in high-throughput bioanalytical mass spectrometry in various areas of drug discovery and development. He is currently a Scientific Director in the Lead Discovery and Optimization (LDO) department at Bristol Myers Squibb in Princeton, NJ.